163 related articles for article (PubMed ID: 3086901)
1. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
Erinoff L; Snodgrass SR
Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
[TBL] [Abstract][Full Text] [Related]
2. Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA.
Reader TA; Gauthier P
J Neural Transm; 1984; 59(3):207-27. PubMed ID: 6234377
[TBL] [Abstract][Full Text] [Related]
3. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
4. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
Shabanov PD; Bul'on VV; Lénárd L
Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
[TBL] [Abstract][Full Text] [Related]
5. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
Hard E; Ahlenius S; Engel J
Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
[TBL] [Abstract][Full Text] [Related]
6. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
Waller SB; Buterbaugh GG
Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
[TBL] [Abstract][Full Text] [Related]
7. Effects of 6-hydroxydopamine or 5,7-dihydroxy-tryptamine on the development of physical dependence on ethanol.
Frye GD; Ellis FW
Drug Alcohol Depend; 1977; 2(5-6):349-59. PubMed ID: 562250
[TBL] [Abstract][Full Text] [Related]
8. Six-hydroxydopamine induced hyperactivity: neither sex differences nor caffeine stimulation are found.
Erinoff L; Kelly PH; Basura M; Snodgrass SR
Pharmacol Biochem Behav; 1984 May; 20(5):707-13. PubMed ID: 6429674
[TBL] [Abstract][Full Text] [Related]
9. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
Pappas B; Ings R; Roberts D
Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
Minnema DJ; Rosecrans JA
Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting depletion of spinal cord 5-hydroxytryptamine or catecholamines after intraspinal injection of 5,7-dihydroxytryptamine or 6-hydroxydopamine to newborn rats.
Carruba MO; Keller HH; Da Prada M
Neurosci Lett; 1983 Feb; 35(2):173-8. PubMed ID: 6190112
[No Abstract] [Full Text] [Related]
13. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
[No Abstract] [Full Text] [Related]
14. Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development.
Waller SB; Buterbaugh GG
Pharmacol Biochem Behav; 1985 Sep; 23(3):473-8. PubMed ID: 3931103
[TBL] [Abstract][Full Text] [Related]
15. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.
Lucot JB; Seiden LS
Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128
[TBL] [Abstract][Full Text] [Related]
16. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
Kantak KM; Hegstrand LR; Eichelman B
Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
[TBL] [Abstract][Full Text] [Related]
17. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
Miller FE; Heffner TG; Kotake C; Seiden LS
Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
[TBL] [Abstract][Full Text] [Related]
18. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
Finn IB; Iuvone PM; Holtzman SG
Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats.
Breese GR; Cooper BR
Brain Res; 1975 Nov; 98(3):517-27. PubMed ID: 1242372
[TBL] [Abstract][Full Text] [Related]
20. Effect of modification of brain serotonin (5-HT), norepinephrine (NE) and dopamine (DA) on ethanol tolerance.
Lê AD; Khanna JM; Kalant H; LeBlanc AE
Psychopharmacology (Berl); 1981; 75(3):231-5. PubMed ID: 6798612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
